Please provide your email address to receive an email when new articles are posted on . At week 28, 88% of patients treated with combination therapy achieved 75% disease severity reduction vs. 47% on ...

PITTSBURGH, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage biotechnology company dedicated to addressing serious diseases with significant unmet needs, ...

LP-310 shows significant improvements in pain and inflammation for oral lichen planus, with favorable safety results in Phase 2a trial. Lipella Pharmaceuticals has announced promising results from its ...

The "Clinical Snapshot" series provides a concise examination of a clinical presentation including history, treatment, patient education, and nursing measures. Using the format here, you are invited ...

Dear Anon.: Nobody knows what causes lichen planus, an uncommon (less than 1% of people) skin condition that may also affect the mouth or vagina. It most often occurs during the ages of 30 to 60. It ...

A survey of US dermatologists revealed low screening rates for common comorbidities in patients with lichen planus (LP), with significant reliance on topical treatments. An anonymous survey with ...

Please provide your email address to receive an email when new articles are posted on . All patients treated with baracitinib for lichen planus had a response at week 12. After 1 week of treatment, 37 ...

Oral lichen planus (OLP) is a chronic mucocutaneous autoimmune skin disease without a proper pathophysiology and approved therapy. As a result, several repurposed drugs have been used in clinical ...

Dr. Frank Bures, a semi-retired dermatologist, has worked in Winona, La Crosse, Viroqua and Red Wing since 1978. He also plays clarinet in the Winona Municipal Band and a couple Dixieland groups.

When your mouth hurts, it’s so uncomfortable that it’s hard to enjoy a meal and sometimes even sleep. You can try something like oral numbing gels or salt-water rinses, but if it doesn’t go away you ...